Search

Roman A Shimanovich

from Brighton, MA
Age ~49
Get Report
Also known as:
Roman Yelena Shimanovich, Roman Y Shimanovich, Rom Shimanovich, Ro Shimanovich, Roman H
Phone and address:
37 Nottinghill Rd, Boston, MA 02135
(929) 247-7024
Related to:
Alla Shimanovich
Connected to:
Chaya Shimanovich, 41Chikako Shimano, 55Tetsuya A Shimano, 53Brian W Shimansky, 39James J Shimansky, 58John J Shimansky, 73Sherri D Shimansky, 58Koshin Shimasaki, 64Perry S Shimasaki, 62Stephen J Shimatzki, 81

Roman Shimanovich Phones & Addresses

  • 37 Nottinghill Rd, Brighton, MA 02135 (929) 247-7024
  • 39 Leamington Rd, Brighton, MA 02135 (617) 787-1963
  • Boston, MA
  • 759 E 10Th St APT 2C, Brooklyn, NY 11230 (718) 859-6170
  • Princeton, NJ
  • 836 Cooper Landing Rd, Cherry Hill, NJ 08002
  • Highland Park, NJ
  • 39 Leamington Rd, Brighton, MA 02135 (646) 321-3818

Work

Company: Amgen Mar 2008 Position: Senior scientist

Education

Degree: PhD School / High School: Princeton University 1997 to 2003 Specialities: Chemistry

Skills

Lc Ms • Drug Development • Formulation • Hplc • Pharmaceutical Industry • Small Molecules • Chemistry • Mass Spectrometry • Crystallization • Uv/Vis • Chromatography • Analytical Chemistry • Pharmaceutics • Solid State Characterization • Drug Discovery • Nmr • High Performance Liquid Chromatography • Liquid Chromatography Mass Spectrometry

Languages

Russian

Interests

Rock Climbing • Cars • Home Improvement • Hiking • Carpentry

Emails

r***[email protected]

Industries

Pharmaceuticals

Resumes

Resumes

Roman Shimanovich Photo 1

Senior Principal Scientist

View page
Location:
P/O Box 1027, Millbrook, AL
Industry:
Pharmaceuticals
Work:
Amgen since Mar 2008
Senior Scientist
Education:
Princeton University 1997 - 2003
PhD, Chemistry Massachusetts Institute of Technology 1993 - 1997
BS, Chemistry, Biology
Skills:
Lc Ms
Drug Development
Formulation
Hplc
Pharmaceutical Industry
Small Molecules
Chemistry
Mass Spectrometry
Crystallization
Uv/Vis
Chromatography
Analytical Chemistry
Pharmaceutics
Solid State Characterization
Drug Discovery
Nmr
High Performance Liquid Chromatography
Liquid Chromatography Mass Spectrometry
Interests:
Rock Climbing
Cars
Home Improvement
Hiking
Carpentry
Languages:
Russian

Publications

Us Patents

Solid State Forms

View page
US Patent:
20200369662, Nov 26, 2020
Filed:
May 20, 2020
Appl. No.:
16/878824
Inventors:
- Thousand Oaks CA, US
Patricia LOPEZ - Woodland Hills CA, US
Prashant AGARWAL - Chelsea MA, US
Albert AMEGADZIE - Moorpark CA, US
Stephanie AZALI - Woodland Hills CA, US
Roman SHIMANOVICH - Brighton MA, US
Ron C. KELLY - Westlake Village CA, US
Darren Leonard REID - Belmont MA, US
Assignee:
AMGEN INC. - Thousand Oaks CA
International Classification:
C07D 471/04
Abstract:
The present disclosure provides crystalline and amorphous forms of 6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-(4-methyl-2-(2-propanyl)-3-pyridinyl)-4-((2S)-2-methyl-4-(2-propenoyl)-1-piperazinyl)pyrido[2,3-d]pyrimidin-2(1H)-one, including several anhydrous, hydrate and solvate forms, and solid state forms thereof, pharmaceutical compositions, and methods of treating a disease mediated by KRAS G12C inhibition.

Polymorphic Forms And Co-Crystals Of A C-Met Inhibitor

View page
US Patent:
20180244696, Aug 30, 2018
Filed:
Apr 30, 2018
Appl. No.:
15/966157
Inventors:
- Thousand Oaks CA, US
Matthew BIO - Belmont MA, US
Melanie COOKE - Arlington MA, US
Katrina W. COPELAND - Sudbury MA, US
Matthew PETERSON - Hopkinton MA, US
Michele POTASHMAN - Cambridge MA, US
Roman SHIMANOVICH - Brighton MA, US
Helming TAN - Thousand Oaks CA, US
International Classification:
C07D 519/00
A61K 31/52
C07C 57/145
C07C 57/10
C07C 55/12
C07C 55/10
C07C 275/02
Abstract:
Provided herein are novel polymorphic forms and co-crystals of a compound useful in the treatment, prevention, or amelioration of cancer. In particular, the invention provides polymorphs and co-crystals of 6-{(1R)-1-[8-fluoro-6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl}-3-(2-methoxyethoxy)-1,6-naphthyridin-5(6H)-one, which is an inhibitor of c-Met.

Polymorphic Forms And Co-Crystals Of A C-Met Inhibitor

View page
US Patent:
20170029443, Feb 2, 2017
Filed:
Oct 14, 2016
Appl. No.:
15/293511
Inventors:
- Thousand Oaks CA, US
Matthew BIO - Santa Barbara CA, US
Melanie COOKE - Arlington MA, US
Katrina W. COPELAND - Sudbury MA, US
Matthew PETERSON - Cambridge MA, US
Michele POTASHMAN - Cambridge MA, US
Roman SHIMANOVICH - Brighton MA, US
Helming TAN - Thousand Oaks CA, US
International Classification:
C07D 519/00
C07C 275/02
C07C 57/10
C07C 55/12
C07C 57/145
C07C 55/10
Abstract:
Provided herein are novel polymorphic forms and co-crystals of a compound useful in the treatment, prevention, or amelioration of cancer. In particular, the invention provides polymorphs and co-crystals of 6-{(1R)-1-[8-fluoro-6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl}-3-(2-methoxyethoxy)-1,6-naphthyridin-5(6H)-one, which is an inhibitor of c-Met.
Control profile
Roman A Shimanovich from Brighton, MA, age ~49 Get Report